NF279 is a suramin analogue that functions as a competitive and reversible antagonist at P2X receptors. It demonstrates exceptional potency at P2X1 receptors, with an IC50 value of 19 nM when a 10-second pre-incubation is used, while exhibiting much weaker activity at other subtypes like P2X2 (IC50 = 0.76 µM), P2X3 (IC50 = 1.62 µM), and P2X4 (IC50 > 300 µM). This compound also shows a greater than 50-fold selectivity for human P2X1 over human P2X7 receptors. Researchers commonly use NF279 as a tool to discriminate between P2X receptor subtypes in native tissue preparations and in vitro electrophysiology studies.
Marketplace OffersShowing from 1 suppliers1 SUPPLIERS · FROM $957.00